Lash Group Enhances Speed-To-Therapy with AI-Powered Benefits Verification
Pharmaceutical Commerce |
Benefit verification is an important process that helps patients access the therapies they need, but can create significant barriers to care. Lash Group's next-generation solution uses artificial intelligence and is designed for continuous improvement so that provider workflows aren’t interrupted and care delivery is faster and more seamless. Read more about their new AI-powered electronic benefit verification (eBV) solution in a recent article published by Pharmaceutical Commerce.